Ventyx Biosciences, Inc.
VTYX
$2.73
$0.083.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.52% | 35.62% | 29.97% | 15.93% | -8.52% |
| Total Depreciation and Amortization | -6.39% | 6.67% | 43.25% | 108.72% | 153.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.25% | -37.14% | -31.63% | -23.93% | 3.69% |
| Change in Net Operating Assets | 89.70% | 111.57% | -281.93% | -9,690.43% | 45.53% |
| Cash from Operations | 33.30% | 40.53% | 21.41% | 1.76% | -4.64% |
| Capital Expenditure | 87.04% | 86.96% | 53.11% | -7.47% | -6.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.10% | -118.97% | -115.05% | 149.13% | 185.84% |
| Cash from Investing | 36.28% | -119.09% | -115.36% | 148.38% | 184.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.69% | -99.77% | 80.80% | 82.68% | -57.06% |
| Repurchase of Common Stock | -- | -- | -- | 91.25% | 91.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | 200.00% |
| Cash from Financing | -72.40% | -74.29% | 128.98% | 189.52% | -55.39% |
| Foreign Exchange rate Adjustments | 480.95% | 286.49% | -358.33% | 12.20% | -400.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.15% | -243.71% | -98.28% | 102.51% | -254.02% |